High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes

CONCLUSIONS: Serum CCL11/Eotaxin-1 is elevated in patients with DSPN and is associated with peripheral nerve dysfunction, in particular sensory nerve conduction velocity, suggesting that serum CCL11/Eotaxin 1 May be a potential biomarker for DSPN.CLINICAL TRIAL REGISTRATION: University Hospital Medical Information Network (UMIN) Clinical Trials Registry (UMIN000040631).PMID:38660919 | DOI:10.1080/00325481.2024.2347196

Source: Postgraduate Medicine - April 25, 2024 Category: Internal Medicine Authors: Yoshimasa Aso Toshie Iijima Teruo Jojima Masahiro Saito Dai Tanuma Masato Kase Shintaro Sakurai Takuya Tomaru Isao Usui Source Type: research